4168.TWO
Price:
$21.6
Market Cap:
$2.33B
GlycoNex Incorporation engages in the development of cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies in Taiwan. The company's development pipeline for the treatment of solid tumors includes GNX102, a humanized monoclonal antibody, currently under phase 1 clinical stage; GNX201, an antibody drug currently under lead optimization stage; GNX202, an antibody drug currently under preclinical stage; and GNX203 and GNX204, antibody drugs currently under target validation stage. It is also involved in the development of SPD (Denosumab), a humanized IgG2 antibody that is in preclinical stage for the treatment of osteoporosis and oncology; and SEA (Aflibercept),...[Read more]
Industry
Biotechnology
IPO Date
2012-06-20
Stock Exchange
TWO
Ticker
4168.TWO
According to GlycoNex Incorporation’s latest financial reports and current stock price. The company's current Current Ratio is 1.67. This represents a change of -6.68% compared to the average of 1.78 of the last 4 quarters.
The mean historical Current Ratio of GlycoNex Incorporation over the last ten years is 8.87. The current 1.67 Current Ratio has changed 1.78% with respect to the historical average. Over the past ten years (40 quarters), 4168.TWO's Current Ratio was at its highest in in the March 2023 quarter at 20.37. The Current Ratio was at its lowest in in the December 2022 quarter at 0.
Average
8.87
Median
7.92
Minimum
0
Maximum
19.52
Discovering the peaks and valleys of GlycoNex Incorporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Current Ratio = 19.52
Minimum Annual Increase = -83.44%
Minimum Annual Current Ratio = 0
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 1.82 | -31.51% |
| 2023 | 2.65 | -83.44% |
| 2022 | 16.03 | 21.59% |
| 2021 | 13.18 | -32.45% |
| 2020 | 19.52 | Infinity% |
The current Current Ratio of GlycoNex Incorporation (4168.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
6.83
5-year avg
10.64
10-year avg
8.87
GlycoNex Incorporation’s Current Ratio is less than TaiRx, Inc. (20.60), less than Steminent Biotherapeutics Inc. (6.33), less than Hcmed (11.14), less than Intech Biopharm Corporation (1.71), less than Gwo Xi Stem Cell Applied Technology Co. , Ltd (3.10), less than Taiwan Bio Therapeutics Co., Ltd (8.15), greater than Sunny Pharmtech Inc. (1.30), less than Anti-Microbial Savior BioteQ Co., Ltd (18.78), less than HeXun Biosciences Co., Ltd. (8.26), greater than Genomics BioSci & Tech. Co.,Ltd. (1.35),
| Company | Current Ratio | Market cap |
|---|---|---|
| 20.60 | $2.54B | |
| 6.33 | $2.82B | |
| 11.14 | $2.29B | |
| 1.71 | $2.46B | |
| 3.10 | $2.70B | |
| 8.15 | $2.29B | |
| 1.30 | $2.10B | |
| 18.78 | $2.62B | |
| 8.26 | $2.56B | |
| 1.35 | $1.74B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GlycoNex Incorporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GlycoNex Incorporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is GlycoNex Incorporation's Current Ratio?
How is the Current Ratio calculated for GlycoNex Incorporation (4168.TWO)?
What is the highest Current Ratio for GlycoNex Incorporation (4168.TWO)?
What is the 3-year average Current Ratio for GlycoNex Incorporation (4168.TWO)?
What is the 5-year average Current Ratio for GlycoNex Incorporation (4168.TWO)?
How does the current Current Ratio for GlycoNex Incorporation (4168.TWO) compare to its historical average?